vs
Side-by-side financial comparison of EVERSPIN TECHNOLOGIES INC. (MRAM) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
EVERSPIN TECHNOLOGIES INC. is the larger business by last-quarter revenue ($14.9M vs $12.6M, roughly 1.2× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -2.0%, a 252.7% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 13.2%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 18.2%).
Everspin Technologies, Inc. is a publicly traded semiconductor company headquartered in Chandler, Arizona, United States. It develops and manufactures discrete magnetoresistive RAM or magnetoresistive random-access memory (MRAM) products, including Toggle MRAM and Spin-Transfer Torque MRAM (STT-MRAM) product families. It also licenses its technology for use in embedded MRAM (eMRAM) applications, magnetic sensor applications as well as performs backend foundry services for eMRAM.
MRAM vs SPRO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.9M | $12.6M |
| Net Profit | $-296.0K | $31.5M |
| Gross Margin | 52.7% | — |
| Operating Margin | 29.0% | — |
| Net Margin | -2.0% | 250.7% |
| Revenue YoY | 13.2% | 24080.8% |
| Net Profit YoY | — | 250.9% |
| EPS (diluted) | $-0.01 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.9M | — | ||
| Q4 25 | $14.8M | $12.6M | ||
| Q3 25 | $14.1M | $0 | ||
| Q2 25 | $13.2M | $0 | ||
| Q1 25 | $13.1M | $12.0K | ||
| Q4 24 | $13.2M | $52.0K | ||
| Q3 24 | $12.1M | $65.0K | ||
| Q2 24 | $10.6M | $114.0K |
| Q1 26 | $-296.0K | — | ||
| Q4 25 | $1.2M | $31.5M | ||
| Q3 25 | $54.0K | $-7.4M | ||
| Q2 25 | $-670.0K | $-1.7M | ||
| Q1 25 | $-1.2M | $-13.9M | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $2.3M | $-17.1M | ||
| Q2 24 | $-2.5M | $-17.9M |
| Q1 26 | 52.7% | — | ||
| Q4 25 | 50.8% | — | ||
| Q3 25 | 51.3% | — | ||
| Q2 25 | 51.3% | — | ||
| Q1 25 | 51.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.2% | — | ||
| Q2 24 | 49.0% | — |
| Q1 26 | 29.0% | — | ||
| Q4 25 | -7.2% | — | ||
| Q3 25 | -11.0% | — | ||
| Q2 25 | -14.9% | — | ||
| Q1 25 | -14.7% | -122758.3% | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -17.5% | -28604.6% | ||
| Q2 24 | -26.5% | -16720.2% |
| Q1 26 | -2.0% | — | ||
| Q4 25 | 8.1% | 250.7% | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | -5.1% | — | ||
| Q1 25 | -8.9% | -115550.0% | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 18.8% | -26380.0% | ||
| Q2 24 | -23.5% | -15668.4% |
| Q1 26 | $-0.01 | — | ||
| Q4 25 | $0.05 | $0.56 | ||
| Q3 25 | $0.00 | $-0.13 | ||
| Q2 25 | $-0.03 | $-0.03 | ||
| Q1 25 | $-0.05 | $-0.25 | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.10 | $-0.32 | ||
| Q2 24 | $-0.12 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.5M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $70.2M | $59.0M |
| Total Assets | $83.2M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.5M | — | ||
| Q4 25 | $44.5M | $40.3M | ||
| Q3 25 | $45.3M | $48.6M | ||
| Q2 25 | $45.0M | $31.2M | ||
| Q1 25 | $42.2M | $48.9M | ||
| Q4 24 | $42.1M | $52.9M | ||
| Q3 24 | $39.6M | $76.3M | ||
| Q2 24 | $36.8M | $63.5M |
| Q1 26 | $70.2M | — | ||
| Q4 25 | $68.9M | $59.0M | ||
| Q3 25 | $65.8M | $26.5M | ||
| Q2 25 | $64.1M | $32.8M | ||
| Q1 25 | $63.0M | $33.8M | ||
| Q4 24 | $62.6M | $46.1M | ||
| Q3 24 | $59.3M | $65.5M | ||
| Q2 24 | $55.4M | $80.5M |
| Q1 26 | $83.2M | — | ||
| Q4 25 | $84.6M | $68.9M | ||
| Q3 25 | $80.3M | $54.2M | ||
| Q2 25 | $78.9M | $62.1M | ||
| Q1 25 | $80.2M | $77.7M | ||
| Q4 24 | $77.8M | $110.5M | ||
| Q3 24 | $72.6M | $135.2M | ||
| Q2 24 | $64.6M | $149.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $570.0K | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $570.0K | — | ||
| Q4 25 | $2.6M | $-8.4M | ||
| Q3 25 | $881.0K | $17.4M | ||
| Q2 25 | $5.0M | $-17.7M | ||
| Q1 25 | $1.4M | $-4.0M | ||
| Q4 24 | $3.8M | $-23.4M | ||
| Q3 24 | $2.8M | $12.8M | ||
| Q2 24 | $1.7M | $-18.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-975.0K | — | ||
| Q3 25 | $543.0K | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $527.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.8M | — | ||
| Q2 24 | $1.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | -6.6% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 22.9% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | 22.9% | — | ||
| Q2 24 | 15.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 6.9% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.19× | -0.26× | ||
| Q3 25 | 16.31× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.16× | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRAM
| Product sales | $14.1M | 95% |
| Licensing, royalty, patent, engineering services and other revenue | $772.0K | 5% |
SPRO
Segment breakdown not available.
